Lee Kalowski

Insider Reports History

Location
Waltham, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lee Kalowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. CFO and President Stock Option (Right to Buy) 161,323 $2,164,955 $13.42 24 Feb 2025 Direct
BICYCLE THERAPEUTICS plc President and CFO Ordinary Shares 30,309 $530,408 $17.50 03 Apr 2023 Direct
Q32 Bio Inc. CFO and President Common Stock 39,938 $138,213 $3.46 02 Dec 2025 Direct
BICYCLE THERAPEUTICS plc President and CFO Employee Stock Option (right to buy) 35,000 03 Jan 2023 Direct

Insider Reports Filed by Lee Kalowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
QTTB Q32 Bio Inc. 02 Dec 2025 1 -$31,395 4 CFO and President 04 Dec 2025, 19:00
QTTB Q32 Bio Inc. 26 Aug 2025 1 -$7,636 4 CFO and President 28 Aug 2025, 19:20
QTTB Q32 Bio Inc. 24 Feb 2025 5 $0 4 CFO and President 27 Feb 2025, 06:01
QTTB Homology Medicines, Inc. 25 Mar 2024 1 $0 4 CFO and President 27 Mar 2024, 17:34
QTTB Homology Medicines, Inc. 25 Mar 2024 0 $0 3 CFO and President 27 Mar 2024, 17:18
BCYC BICYCLE THERAPEUTICS plc 03 Apr 2023 1 -$7,937 4 President and CFO 05 Apr 2023, 16:41
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2023 3 -$52,744 4 President and CFO 05 Jan 2023, 20:12
BCYC BICYCLE THERAPEUTICS plc 03 Jan 2022 2 $0 4 President and CFO 05 Jan 2022, 16:20
BCYC BICYCLE THERAPEUTICS plc 02 Sep 2021 3 -$301,800 4 President and CFO 03 Sep 2021, 16:49
BCYC BICYCLE THERAPEUTICS plc 26 Aug 2021 6 -$224,493 4 President and CFO 27 Aug 2021, 18:31
BCYC BICYCLE THERAPEUTICS plc 23 Aug 2021 3 -$235,650 4 President and CFO 25 Aug 2021, 17:45
BCYC BICYCLE THERAPEUTICS plc 29 Jul 2021 5 -$373,448 4 President and CFO 30 Jul 2021, 18:21